ClinicalTrials.gg
Not yet recruitingNCT07938957Updated Nov 16, 2026

Will Use Of A Digital AI-guided Anamnestic Support Instrument And Use Of Digitally Monitoring Of Therapy Improve Headache Care And Outcome?

An observational study in Migraine and Headache Disorders, sponsored by Region Stockholm. Not yet recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Region Stockholm · Observational

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
600
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 38 studies in Migraine Disorders with a site in Sweden — 6 open to participants now, 9 under way, 3 of them phase 3. Migraine Disorders · Sweden.

Started
2027
the only one that year
Observational
5 of 38
1 open now
Registered
38th of 38
by date

Among the 38 studies in Migraine Disorders with a site in Sweden, this one is the only one that started in 2027, is one of 5 observational ones, and was the 38th registered.

Migraine Disorders

1,658 studies on the registry are indexed under Migraine Disorders; 339 are open to participants now.

Browse Migraine Disorders studies →

Open to participants now

6 of the 38 studies in Migraine Disorders with a site in Sweden are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 217 Migraine Disorders studies recruiting now, 66 (30%) set no upper age limit and 136 (63%) stop at 75 or younger; 44 take children under 18; 37 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Migraine Disorders with a site in Sweden, or all of them as a file.
02

Study summary

This study aims to:

Develop and validate a Headache Evaluation to support Anamnesis and Diagnostics (HEAD)-instrument for use to improve consultation time and support thorough headache anamnesis and history taking at the first specialist headache consultation (test study) addressing a well-documented gap in current care and directly operationalising the H@H principle of extending structured clinical support into the patient's pathway before hospital contact.

Improve headache care by providing a more digital longitudinal support from first visit and during follow up of chronic severe headache disorders, with primary focus on migraines, with better and more timely assessment of treatment response and disease burden to promote appropriate change of care regime (implementation study).

03

Conditions studied

  • Migraine
  • Headache Disorders

Keywords

  • digital care
  • migraine
  • headache disorders
  • diagnostics
  • care infrastructure
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Testing phase of the study developing the HEAD instrument: Patients attending headache clinics at the three sites (300 patients in total) will be included, 150 will be recruited for the development phase and 150 for the validation phase.

Implementation phase: Patients (300 patients in total - three recruiting sites) with new referal to the clinic will be included in the digital pathway including the HEAD instrument and digital follow-up questionnaires and headache diary. Depending on results for the testing phase this phase will be adjusted.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients referred to or already attending the clinic/department
  • Headache and/or facial pain is the primary reason for consultation

Exclusion criteria

Exclusion Criteria:

  • Insufficient answered questionnaire - more than 30% missing data.
  • not having internet experience or access
  • insufficient native language knowledge
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
600 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with symtoms of headache/facial pain

    Patients seeking medical help at specialist care for headache or facial pain disorder, largest group of patients will be patients with migraine diagnosis

    Diagnostic Test: HEAD instrument

Interventions

  • Diagnostic testHEAD instrument

    Using patients own input prior to first visit at a specialist center (by filling in a advanced on-line questionnaire) we intend to support the clinical visit so that the clinican will recieve an anamnestic summarise of the patients history by using a by project developed AI module which will also be validated in this study and integrated in a digital pathway in treating severe migraine and headache patients in specialised care enviroment.

06

What researchers measure

Primary outcomes

  1. Headache diagnosis

    Provide a high agreement between the HEAD instruments output of diagnosis and treatment suggestions compared to reference standard (independent blinded medical record review and diagnosis and treatment standards)?

    Time frame: 1,5 year

  2. Headache anamnesis

    Produce a good summary of patients' anamnesis according to physicians?

    Time frame: 1,5 year

  3. Headache severity

    Detect headache severity and thereby support earlier identification of patients at risk of migraine chronification?

    Time frame: 1,5 Year

Secondary outcomes

  1. Userfriendliness

    Is the developed questionnaire and HEAD instrument user-friendly for physicians and patients based on a 7-point Likert scale answers?

    Time frame: 1,5 year

  2. Agreement with set diagnosis

    To what extent does the HEAD instrument show agreement with set diagnosis from clinicians?

    Time frame: 1,5 year

  3. Omission rate of HEAD instrument

    What is the omission rate or citation rate of the HEAD instrument (the diagnosis does not appear by the top three diagnosis suggestions from the HEAD instrument or appears in at least any of the three top three diagnosis suggestions)?

    Time frame: 1,5 year

  4. Time efficiency

    Does the HEAD instrument and digital follow up improve the use of consultation time and with higher quality for the physicians and patients?

    Time frame: 1,5 year

Other outcomes

  1. Implementation study

    How well does a more digital pathway for migaine diagnosis, support and follow up improve the overall care for headache patients?

    Time frame: 3 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jan 2030, 36 months later.

Of 132 non-industry observational studies under Migraine Disorders, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 72. This study's planned 36 months is above that.

Counting every sponsor, half of 160 studies reached it within 27 months; a quarter within 13 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 16, 2026
StartEst.
Jan 15, 2027
Primary completionEst.
Jan 15, 2030
CompletionEst.
Dec 31, 2030
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938957
Lead sponsor
Region Stockholm
Collaborators
Aarhus University Hospital, Erasmus Medical Center, Karolinska University Hospital, Ancora Health B.V., Salvia BioElectronics, Forward Faster AI B.V., Emento Predict By Research and Consulting S.L., European Migraine and Headache Alliance (EMHA)
Responsible party
Sponsor
First posted
Nov 16, 2026
Start date
Jan 15, 2027 (estimated)
Primary completion
Jan 15, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Nov 16, 2026

Study contacts

Anna Sundholm
Contact
anna.sundholm@regionstockholm.se
+46 (0)8 123 82 054
Andrea Carmine Belin
Contact
andrea.carmine.belin@ki.se
+46 (0)8 524 87 051

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion